IMRX vs POOL · $124.2M cap vs P/E 18, rev $5.31B
Immuneering Corp (IMRX) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Immuneering Corp (IMRX) is a biotechnology company listed on US.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported IMRX revenue for 2023-12-31 was $0. Net income was -$53.5M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. IMRX currently screens at market cap $124.2M.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
IMRX currently screens at market cap $124.2M. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the IMRX and POOL stock pages for the full models.
Not investment advice.